Lescol XL · DIN 02250527 · 80 mg · extended release tablet
General benefit; Health Canada lists this DIN as Cancelled post market since 2021-06-14 — choose a marketed DIN from the same-category list.Discontinued June 14, 2021 · checked November 19, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2021-06-14 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2021-06-14 — choose a marketed DIN from the same-category list.
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Lescol XL · DIN 02250527
Manufacturer: Novartis Pharma Canada Inc.; listing date 2005-02-22
Health Canada: Cancelled post market since 2021-06-14 · brand LESCOL XL · ATC C10AA04 FLUVASTATIN · form Tablet (extended-release) · route Oral · ingredients FLUVASTATIN (FLUVASTATIN SODIUM) 80 MG · company Novartis pharmaceuticals canada inc · schedule Prescription
Lescol XL: Formulary list price $1.62 per unit (the source does not state the unit; exact figure $1.6225). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02250527)
Source record
DIN 02250527: Lescol XL
Raw flags: chronicUseMed=Y, sec3=Y
Item: 240600050; group id 304; item number 0666; lccId None; manufacturer id NOV
Source form: ER Tab; strength: 80mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $1.6225; ministry $1.6225
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02250527
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=73534
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Cancelled post market since June 14, 2021 — choose a marketed DIN from the same-category list.